{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:10:59Z","timestamp":1790039459557,"version":"4.0.1"},"reference-count":267,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113960"],"award-info":[{"award-number":["R01NS113960"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS121077"],"award-info":[{"award-number":["R01NS121077"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS127939"],"award-info":[{"award-number":["R21NS127939"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS126342"],"award-info":[{"award-number":["R01NS126342"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS136423"],"award-info":[{"award-number":["R01NS136423"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113960-02S1"],"award-info":[{"award-number":["R01NS113960-02S1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31NS125949"],"award-info":[{"award-number":["F31NS125949"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS095988"],"award-info":[{"award-number":["R01NS095988"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS126342"],"award-info":[{"award-number":["R01NS126342"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS136423"],"award-info":[{"award-number":["R01NS136423"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leon Levy Fellowship in Neuroscience McGraw Fellowship in Neurology Research"},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R25GM152362"],"award-info":[{"award-number":["1R25GM152362"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG085144"],"award-info":[{"award-number":["R21AG085144"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["UG3MH129381"],"award-info":[{"award-number":["UG3MH129381"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson Foundation Starr Foundation"},{"name":"HHMI Transformative Technology 2019 program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59441-7","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:34:10Z","timestamp":1746077650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Virginia","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-0338","authenticated-orcid":false,"given":"Julita","family":"Chlebowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlton","family":"Gaskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-9415","authenticated-orcid":false,"given":"Juan A.","family":"Briano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Komer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-3299","authenticated-orcid":false,"given":"Andr\u00e9","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey","family":"Jhalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eseosa","family":"Uwaifo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1746-8453","authenticated-orcid":false,"given":"Luca S.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian E.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Przedborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-557X","authenticated-orcid":false,"given":"Diane A.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8206-1007","authenticated-orcid":false,"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-2419","authenticated-orcid":false,"given":"Manu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-248X","authenticated-orcid":false,"given":"Jacqueline","family":"Burr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"59441_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev.neuro.26.041002.131412","volume":"27","author":"TC Sudhof","year":"2004","unstructured":"Sudhof, T. C. The synaptic vesicle cycle. Annu Rev. Neurosci. 27, 509\u2013547 (2004).","journal-title":"Annu Rev. Neurosci."},{"key":"59441_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.4103\/1673-5374.233445","volume":"13","author":"WJ Fan","year":"2018","unstructured":"Fan, W. J. et al. Synaptic aging disrupts synaptic morphology and function in cerebellar purkinje cells. Neural Regen. Res 13, 1019\u20131025 (2018).","journal-title":"Neural Regen. Res"},{"key":"59441_CR3","doi-asserted-by":"crossref","unstructured":"Soukup, S. F., Vanhauwaert, R. & Verstreken, P. Parkinson\u2019s disease: convergence on synaptic homeostasis. EMBO J 37, e98960 (2018).","DOI":"10.15252\/embj.201898960"},{"key":"59441_CR4","doi-asserted-by":"publisher","first-page":"626128","DOI":"10.3389\/fncel.2021.626128","volume":"15","author":"NZ Gcwensa","year":"2021","unstructured":"Gcwensa, N. Z., Russell, D. L., Cowell, R. M. & Volpicelli-Daley, L. A. Molecular mechanisms underlying synaptic and axon degeneration in parkinson\u2019s disease. Front Cell Neurosci. 15, 626128 (2021).","journal-title":"Front Cell Neurosci."},{"key":"59441_CR5","doi-asserted-by":"publisher","first-page":"33586","DOI":"10.1073\/pnas.2011870117","volume":"117","author":"Z Taoufiq","year":"2020","unstructured":"Taoufiq, Z. et al. Hidden proteome of synaptic vesicles in the mammalian brain. Proc. Natl Acad. Sci. USA 117, 33586\u201333596 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR6","doi-asserted-by":"publisher","first-page":"111024","DOI":"10.1016\/j.brainresbull.2024.111024","volume":"215","author":"S He","year":"2024","unstructured":"He, S., Ru, Q., Chen, L., Xu, G. & Wu, Y. Advances in animal models of parkinson\u2019s disease. Brain Res Bull. 215, 111024 (2024).","journal-title":"Brain Res Bull."},{"key":"59441_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00401-023-02601-0","volume":"146","author":"M Flores-Leon","year":"2023","unstructured":"Flores-Leon, M. & Outeiro, T. F. More than meets the eye in parkinson\u2019s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathol. 146, 369\u2013385 (2023).","journal-title":"Acta Neuropathol."},{"key":"59441_CR8","doi-asserted-by":"publisher","first-page":"105580","DOI":"10.1016\/j.nbd.2021.105580","volume":"163","author":"BM Schilder","year":"2022","unstructured":"Schilder, B. M., Navarro, E. & Raj, T. Multi-omic insights into parkinson\u2019s disease: From genetic associations to functional mechanisms. Neurobiol. Dis. 163, 105580 (2022).","journal-title":"Neurobiol. Dis."},{"key":"59441_CR9","doi-asserted-by":"crossref","unstructured":"Dahabiyeh, L. A., Nimer, R. M., Rashed, M., Wells, J. D. & Fiehn, O. Serum-based lipid panels for diagnosis of idiopathic parkinson\u2019s disease. Metabolites 13, 990 (2023).","DOI":"10.3390\/metabo13090990"},{"key":"59441_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","volume":"147","author":"J Rutledge","year":"2024","unstructured":"Rutledge, J. et al. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol. 147, 52 (2024).","journal-title":"Acta Neuropathol."},{"key":"59441_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1997","volume":"16","author":"B Zhu","year":"2024","unstructured":"Zhu, B. et al. Single-cell transcriptomic and proteomic analysis of parkinson\u2019s disease brains. Sci. Transl. Med 16, eabo1997 (2024).","journal-title":"Sci. Transl. Med"},{"key":"59441_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48961-3","volume":"15","author":"J Hallqvist","year":"2024","unstructured":"Hallqvist, J. et al. Plasma proteomics identify biomarkers predicting parkinson\u2019s disease up to 7 years before symptom onset. Nat. Commun. 15, 4759 (2024).","journal-title":"Nat. Commun."},{"key":"59441_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/brainsci13081166","volume":"13","author":"J Qiu","year":"2023","unstructured":"Qiu, J. et al. Lipid metabolism disorder in cerebrospinal fluid related to parkinson\u2019s disease. Brain Sci. 13, 1166 (2023).","journal-title":"Brain Sci."},{"key":"59441_CR14","doi-asserted-by":"publisher","first-page":"1424056","DOI":"10.3389\/fnagi.2024.1424056","volume":"16","author":"Y Qin","year":"2024","unstructured":"Qin, Y. et al. Plasma lipidome, circulating inflammatory proteins, and parkinson\u2019s disease: a mendelian randomization study. Front Aging Neurosci. 16, 1424056 (2024).","journal-title":"Front Aging Neurosci."},{"key":"59441_CR15","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1002\/pmic.200600357","volume":"6","author":"J Burr\u00e9","year":"2006","unstructured":"Burr\u00e9, J. et al. Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques. Proteomics 6, 6250\u20136262 (2006).","journal-title":"Proteomics"},{"key":"59441_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1523\/JNEUROSCI.4074-09.2010","volume":"30","author":"M Gronborg","year":"2010","unstructured":"Gronborg, M. et al. Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J. Neurosci. 30, 2\u201312 (2010).","journal-title":"J. Neurosci."},{"key":"59441_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","volume":"127","author":"S Takamori","year":"2006","unstructured":"Takamori, S. et al. Molecular anatomy of a trafficking organelle. Cell 127, 831\u2013846 (2006).","journal-title":"Cell"},{"key":"59441_CR18","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1523\/JNEUROSCI.20-13-04904.2000","volume":"20","author":"S Takamori","year":"2000","unstructured":"Takamori, S., Riedel, D. & Jahn, R. Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles. J. Neurosci. 20, 4904\u20134911 (2000).","journal-title":"J. Neurosci."},{"key":"59441_CR19","doi-asserted-by":"publisher","first-page":"108966","DOI":"10.1016\/j.abb.2021.108966","volume":"709","author":"B Binotti","year":"2021","unstructured":"Binotti, B., Jahn, R. & Perez-Lara, A. An overview of the synaptic vesicle lipid composition. Arch. Biochem Biophys. 709, 108966 (2021).","journal-title":"Arch. Biochem Biophys."},{"key":"59441_CR20","doi-asserted-by":"publisher","unstructured":"Ahrends, R., Ellis, S. R., Verhelst, S. H. L. & Kreutz, M. R. Synaptoneurolipidomics: lipidomics in the study of synaptic function. Trends Biochem. Sci. https:\/\/doi.org\/10.1016\/j.tibs.2024.12.004 (2025).","DOI":"10.1016\/j.tibs.2024.12.004"},{"key":"59441_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407375121","volume":"121","author":"U Kravcenko","year":"2024","unstructured":"Kravcenko, U. et al. Molecular architecture of synaptic vesicles. Proc. Natl Acad. Sci. USA 121, e2407375121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/35025070","volume":"407","author":"S Takamori","year":"2000","unstructured":"Takamori, S., Rhee, J. S., Rosenmund, C. & Jahn, R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407, 189\u2013194 (2000).","journal-title":"Nature"},{"key":"59441_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2013.02.027","volume":"78","author":"J Boyken","year":"2013","unstructured":"Boyken, J. et al. Molecular profiling of synaptic vesicle docking sites reveals novel proteins but few differences between glutamatergic and GABAergic synapses. Neuron 78, 285\u2013297 (2013).","journal-title":"Neuron"},{"key":"59441_CR24","first-page":"32","volume":"5","author":"L Bragina","year":"2011","unstructured":"Bragina, L. et al. Analysis of Synaptotagmin, SV2, and Rab3 expression in cortical glutamatergic and GABAergic Axon Terminals. Front Cell Neurosci. 5, 32 (2011).","journal-title":"Front Cell Neurosci."},{"key":"59441_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.neuroscience.2007.07.014","volume":"152","author":"A Peters","year":"2008","unstructured":"Peters, A., Sethares, C. & Luebke, J. I. Synapses are lost during aging in the primate prefrontal cortex. Neuroscience 152, 970\u2013981 (2008).","journal-title":"Neuroscience"},{"key":"59441_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0006-8993(82)90514-5","volume":"239","author":"I Adams","year":"1982","unstructured":"Adams, I. & Jones, D. G. Quantitative ultrastructural changes in rat cortical synapses during early-, mid- and late-adulthood. Brain Res 239, 349\u2013363 (1982).","journal-title":"Brain Res"},{"key":"59441_CR27","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1523\/JNEUROSCI.08-04-01096.1988","volume":"8","author":"MD Applegate","year":"1988","unstructured":"Applegate, M. D. & Landfield, P. W. Synaptic vesicle redistribution during hippocampal frequency potentiation and depression in young and aged rats. J. Neurosci. 8, 1096\u20131111 (1988).","journal-title":"J. Neurosci."},{"key":"59441_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2010.03.020","volume":"168","author":"JJ Soghomonian","year":"2010","unstructured":"Soghomonian, J. J., Sethares, C. & Peters, A. Effects of age on axon terminals forming axosomatic and axodendritic inhibitory synapses in prefrontal cortex. Neuroscience 168, 74\u201381 (2010).","journal-title":"Neuroscience"},{"key":"59441_CR29","doi-asserted-by":"publisher","first-page":"8778","DOI":"10.1523\/JNEUROSCI.1494-11.2012","volume":"32","author":"ML Toth","year":"2012","unstructured":"Toth, M. L. et al. Neurite sprouting and synapse deterioration in the aging caenorhabditis elegans nervous system. J. Neurosci. 32, 8778\u20138790 (2012).","journal-title":"J. Neurosci."},{"key":"59441_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plipres.2011.11.004","volume":"51","author":"MD Ledesma","year":"2012","unstructured":"Ledesma, M. D., Martin, M. G. & Dotti, C. G. Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog. Lipid Res 51, 23\u201335 (2012).","journal-title":"Prog. Lipid Res"},{"key":"59441_CR31","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1113\/JP270590","volume":"594","author":"J Egawa","year":"2016","unstructured":"Egawa, J., Pearn, M. L., Lemkuil, B. P., Patel, P. M. & Head, B. P. Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function. J. Physiol. 594, 4565\u20134579 (2016).","journal-title":"J. Physiol."},{"key":"59441_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga, S., Sekiya, H., Kondru, N., Ross, O. A. & Dickson, D. W. Neuropathology and molecular diagnosis of Synucleinopathies. Mol. Neurodegener. 16, 83 (2021).","journal-title":"Mol. Neurodegener."},{"key":"59441_CR33","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804\u20132815 (1988).","journal-title":"J. Neurosci."},{"key":"59441_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai, A. et al. The precursor protein of non-A beta component of alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467\u2013475 (1995).","journal-title":"Neuron"},{"key":"59441_CR35","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","volume":"20","author":"PJ Kahle","year":"2000","unstructured":"Kahle, P. J. et al. Subcellular localization of wild-type and parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J. Neurosci. 20, 6365\u20136373 (2000).","journal-title":"J. Neurosci."},{"key":"59441_CR36","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin, D. E. et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797\u20138807 (2002).","journal-title":"J. Neurosci."},{"key":"59441_CR37","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","volume":"24","author":"L Yavich","year":"2004","unstructured":"Yavich, L., Tanila, H., Vepsalainen, S. & Jakala, P. Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci. 24, 11165\u201311170 (2004).","journal-title":"J. Neurosci."},{"key":"59441_CR38","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy, D. D., Rueter, S. M., Trojanowski, J. Q. & Lee, V. M. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214\u20133220 (2000).","journal-title":"J. Neurosci."},{"key":"59441_CR39","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1073\/pnas.1903049116","volume":"116","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling. Proc. Natl Acad. Sci. USA 116, 11113\u201311115 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00592","volume":"2","author":"J Diao","year":"2013","unstructured":"Diao, J. et al. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2. Elife 2, e00592 (2013).","journal-title":"Elife"},{"key":"59441_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.774650","volume":"9","author":"KE Fouke","year":"2021","unstructured":"Fouke, K. E. et al. Synuclein regulates synaptic vesicle clustering and docking at a vertebrate synapse. Front Cell Dev. Biol. 9, 774650 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"59441_CR42","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9, J. et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667 (2010).","journal-title":"Science"},{"key":"59441_CR43","doi-asserted-by":"publisher","first-page":"167714","DOI":"10.1016\/j.jmb.2022.167714","volume":"435","author":"V Gao","year":"2023","unstructured":"Gao, V., Briano, J. A., Komer, L. E. & Burre, J. Functional and pathological effects of alpha-synuclein on synaptic SNARE complexes. J. Mol. Biol. 435, 167714 (2023).","journal-title":"J. Mol. Biol."},{"key":"59441_CR44","doi-asserted-by":"publisher","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"E Jo","year":"2000","unstructured":"Jo, E., McLaurin, J., Yip, C. M., St George-Hyslop, P. & Fraser, P. E. alpha-synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275, 34328\u201334334 (2000).","journal-title":"J. Biol. Chem."},{"key":"59441_CR45","doi-asserted-by":"publisher","first-page":"31664","DOI":"10.1074\/jbc.M504894200","volume":"280","author":"S Kubo","year":"2005","unstructured":"Kubo, S. et al. A combinatorial code for the interaction of alpha-synuclein with membranes. J. Biol. Chem. 280, 31664\u201331672 (2005).","journal-title":"J. Biol. Chem."},{"key":"59441_CR46","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1523\/JNEUROSCI.0094-07.2007","volume":"27","author":"AD Gitler","year":"2007","unstructured":"Gitler, A. D. & Shorter, J. Prime time for alpha-synuclein. J. Neurosci. 27, 2433\u20132434 (2007).","journal-title":"J. Neurosci."},{"key":"59441_CR47","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","volume":"288","author":"CH Westphal","year":"2013","unstructured":"Westphal, C. H. & Chandra, S. S. Monomeric synucleins generate membrane curvature. J. Biol. Chem. 288, 1829\u20131840 (2013).","journal-title":"J. Biol. Chem."},{"key":"59441_CR48","doi-asserted-by":"publisher","first-page":"40186","DOI":"10.1074\/jbc.M305326200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu, M., Li, J. & Fink, A. L. The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J. Biol. Chem. 278, 40186\u201340197 (2003).","journal-title":"J. Biol. Chem."},{"key":"59441_CR49","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","volume":"35","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9, J., Sharma, M. & Sudhof, T. C. Definition of a molecular pathway mediating alpha-synuclein neurotoxicity. J. Neurosci. 35, 5221\u20135232 (2015).","journal-title":"J. Neurosci."},{"key":"59441_CR50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1021\/acschemneuro.0c00819","volume":"12","author":"AS Kurochka","year":"2021","unstructured":"Kurochka, A. S., Yushchenko, D. A., Bour, P. & Shvadchak, V. V. Influence of lipid membranes on alpha-synuclein aggregation. ACS Chem. Neurosci. 12, 825\u2013830 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"59441_CR51","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"59441_CR52","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer, M. L. & Schulz-Schaeffer, W. J. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27, 1405\u20131410 (2007).","journal-title":"J. Neurosci."},{"key":"59441_CR53","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","volume":"30","author":"DA Scott","year":"2010","unstructured":"Scott, D. A. et al. A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J. Neurosci. 30, 8083\u20138095 (2010).","journal-title":"J. Neurosci."},{"key":"59441_CR54","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1523\/JNEUROSCI.2581-13.2014","volume":"34","author":"KJ Spinelli","year":"2014","unstructured":"Spinelli, K. J. et al. Presynaptic alpha-synuclein aggregation in a mouse model of parkinson\u2019s disease. J. Neurosci. 34, 2037\u20132050 (2014).","journal-title":"J. Neurosci."},{"key":"59441_CR55","doi-asserted-by":"publisher","first-page":"34393","DOI":"10.1074\/jbc.M004851200","volume":"275","author":"RJ Perrin","year":"2000","unstructured":"Perrin, R. J., Woods, W. S., Clayton, D. F. & George, J. M. Interaction of human alpha-synuclein and parkinson\u2019s disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J. Biol. Chem. 275, 34393\u201334398 (2000).","journal-title":"J. Biol. Chem."},{"key":"59441_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","volume":"315","author":"E Jo","year":"2002","unstructured":"Jo, E., Fuller, N., Rand, R. P., St George-Hyslop, P. & Fraser, P. E. Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P alpha-synuclein. J. Mol. Biol. 315, 799\u2013807 (2002).","journal-title":"J. Mol. Biol."},{"key":"59441_CR57","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1021\/bi010616g","volume":"40","author":"J Li","year":"2001","unstructured":"Li, J., Uversky, V. N. & Fink, A. L. Effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40, 11604\u201311613 (2001).","journal-title":"Biochemistry"},{"key":"59441_CR58","doi-asserted-by":"publisher","first-page":"15227","DOI":"10.1523\/JNEUROSCI.3545-12.2012","volume":"32","author":"J Burr\u00e9","year":"2012","unstructured":"Burr\u00e9, J., Sharma, M. & Sudhof, T. C. Systematic mutagenesis of alpha-synuclein reveals distinct sequence requirements for physiological and pathological activities. J. Neurosci. 32, 15227\u201315242 (2012).","journal-title":"J. Neurosci."},{"key":"59441_CR59","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/mds.29162","volume":"37","author":"K Daida","year":"2022","unstructured":"Daida, K. et al. alpha-synuclein v15a variant in familial parkinson\u2019s disease exhibits a weaker lipid-binding property. Mov. Disord. 37, 2075\u20132085 (2022).","journal-title":"Mov. Disord."},{"key":"59441_CR60","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/mds.28534","volume":"36","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. A Novel SNCA A30G mutation causes familial parkinson\u2019s disease. Mov. Disord. 36, 1624\u20131633 (2021).","journal-title":"Mov. Disord."},{"key":"59441_CR61","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","volume":"23","author":"MB Fares","year":"2014","unstructured":"Fares, M. B. et al. The novel parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of alpha-synuclein, and enhances its secretion and nuclear localization in cells. Hum. Mol. Genet 23, 4491\u20134509 (2014).","journal-title":"Hum. Mol. Genet"},{"key":"59441_CR62","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1021\/bi5010365","volume":"53","author":"D Ghosh","year":"2014","unstructured":"Ghosh, D. et al. The newly discovered parkinson\u2019s disease associated finnish mutation (A53E) attenuates alpha-synuclein aggregation and membrane binding. Biochemistry 53, 6419\u20136421 (2014).","journal-title":"Biochemistry"},{"key":"59441_CR63","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1021\/acs.biochem.8b00314","volume":"57","author":"GM Mohite","year":"2018","unstructured":"Mohite, G. M. et al. Comparison of kinetics, toxicity, oligomer formation, and membrane binding capacity of alpha-synuclein familial mutations at the A53 Site, including the newly discovered A53V mutation. Biochemistry 57, 5183\u20135187 (2018).","journal-title":"Biochemistry"},{"key":"59441_CR64","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1021\/ja909247j","volume":"132","author":"M Drescher","year":"2010","unstructured":"Drescher, M., van Rooijen, B. D., Veldhuis, G., Subramaniam, V. & Huber, M. A stable lipid-induced aggregate of alpha-synuclein. J. Am. Chem. Soc. 132, 4080\u20134082 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"59441_CR65","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/bi0121353","volume":"41","author":"MJ Volles","year":"2002","unstructured":"Volles, M. J. & Lansbury, P. T. Jr Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to parkinson\u2019s disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595\u20134602 (2002).","journal-title":"Biochemistry"},{"key":"59441_CR66","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/09687680802467977","volume":"25","author":"J Madine","year":"2008","unstructured":"Madine, J., Hughes, E., Doig, A. J. & Middleton, D. A. The effects of alpha-synuclein on phospholipid vesicle integrity: a study using 31P NMR and electron microscopy. Mol. Membr. Biol. 25, 518\u2013527 (2008).","journal-title":"Mol. Membr. Biol."},{"key":"59441_CR67","doi-asserted-by":"publisher","first-page":"16873","DOI":"10.1074\/jbc.M210136200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu, M. & Fink, A. L. Lipid binding inhibits alpha-synuclein fibril formation. J. Biol. Chem. 278, 16873\u201316877 (2003).","journal-title":"J. Biol. Chem."},{"key":"59441_CR68","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbamem.2009.03.010","volume":"1788","author":"BD van Rooijen","year":"2009","unstructured":"van Rooijen, B. D., Claessens, M. M. & Subramaniam, V. Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochim Biophys. Acta 1788, 1271\u20131278 (2009).","journal-title":"Biochim Biophys. Acta"},{"key":"59441_CR69","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1073\/pnas.1914670117","volume":"117","author":"JK Hannestad","year":"2020","unstructured":"Hannestad, J. K. et al. Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric alpha-synuclein. Proc. Natl Acad. Sci. USA 117, 14178\u201314186 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR70","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1021\/acs.biochem.2c00160","volume":"61","author":"HM Sanders","year":"2022","unstructured":"Sanders, H. M., Kostelic, M. M., Zak, C. K. & Marty, M. T. Lipids and EGCG affect alpha-synuclein association and disruption of nanodiscs. Biochemistry 61, 1014\u20131021 (2022).","journal-title":"Biochemistry"},{"key":"59441_CR71","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer, D. & Edwards, R. H. The physiological role of alpha-synuclein and its relationship to parkinson\u2019s disease. J. Neurochem 150, 475\u2013486 (2019).","journal-title":"J. Neurochem"},{"key":"59441_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 14, 176 (2023).","journal-title":"Cell Death Dis."},{"key":"59441_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21027-4","volume":"12","author":"WK Man","year":"2021","unstructured":"Man, W. K. et al. The docking of synaptic vesicles on the presynaptic membrane induced by alpha-synuclein is modulated by lipid composition. Nat. Commun. 12, 927 (2021).","journal-title":"Nat. Commun."},{"key":"59441_CR74","doi-asserted-by":"crossref","unstructured":"Gao, V., Crawford, C. V. & Burre, J. The Gut-Brain Axis in Parkinson\u2019s Disease. Cold Spring Harb Perspect Med, 13, 782082 (2024).","DOI":"10.1101\/cshperspect.a041618"},{"key":"59441_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of parkinson\u2019s disease. Lancet 403, 283\u2013292 (2024).","journal-title":"Lancet"},{"key":"59441_CR76","doi-asserted-by":"publisher","first-page":"117242","DOI":"10.1016\/j.lfs.2019.117242","volume":"242","author":"S Wang","year":"2020","unstructured":"Wang, S., Lai, X., Deng, Y. & Song, Y. Correlation between mouse age and human age in anti-tumor research: Significance and method establishment. Life Sci. 242, 117242 (2020).","journal-title":"Life Sci."},{"key":"59441_CR77","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O. M. & Sudhof, T. C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383\u2013396 (2005).","journal-title":"Cell"},{"key":"59441_CR78","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet, M. F. et al. A progressive mouse model of parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9, 297\u2013314 (2012).","journal-title":"Neurotherapeutics"},{"key":"59441_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34490-9","volume":"8","author":"DL Price","year":"2018","unstructured":"Price, D. L. et al. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson\u2019s disease. Sci. Rep. 8, 16165 (2018).","journal-title":"Sci. Rep."},{"key":"59441_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-017-0341-8","volume":"18","author":"R Rabl","year":"2017","unstructured":"Rabl, R. et al. Early start of progressive motor deficits in Line 61 alpha-synuclein transgenic mice. BMC Neurosci. 18, 22 (2017).","journal-title":"BMC Neurosci."},{"key":"59441_CR81","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming, S. M. et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J. Neurosci. 24, 9434\u20139440 (2004).","journal-title":"J. Neurosci."},{"key":"59441_CR82","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jnr.10231","volume":"68","author":"E Rockenstein","year":"2002","unstructured":"Rockenstein, E. et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J. Neurosci. Res 68, 568\u2013578 (2002).","journal-title":"J. Neurosci. Res"},{"key":"59441_CR83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-9-18","volume":"9","author":"CR Overk","year":"2014","unstructured":"Overk, C. R. et al. Hippocampal neuronal cells that accumulate alpha-synuclein fragments are more vulnerable to Abeta oligomer toxicity via mGluR5\u2013implications for dementia with Lewy bodies. Mol. Neurodegener. 9, 18 (2014).","journal-title":"Mol. Neurodegener."},{"key":"59441_CR84","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1093\/brain\/aww238","volume":"139","author":"W Wrasidlo","year":"2016","unstructured":"Wrasidlo, W. et al. A de novo compound targeting alpha-synuclein improves deficits in models of parkinson\u2019s disease. Brain 139, 3217\u20133236 (2016).","journal-title":"Brain"},{"key":"59441_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0455-9","volume":"12","author":"C Kim","year":"2015","unstructured":"Kim, C. et al. Hypoestoxide reduces neuroinflammation and alpha-synuclein accumulation in a mouse model of Parkinson\u2019s disease. J. Neuroinflammation 12, 236 (2015).","journal-title":"J. Neuroinflammation"},{"key":"59441_CR86","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic, S. et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl Acad. Sci. USA 110, E4016\u2013E4025 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR87","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","volume":"25","author":"Y Chu","year":"2007","unstructured":"Chu, Y. & Kordower, J. H. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson\u2019s disease? Neurobiol. Dis. 25, 134\u2013149 (2007).","journal-title":"Neurobiol. Dis."},{"key":"59441_CR88","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","volume":"24","author":"W Li","year":"2004","unstructured":"Li, W. et al. Stabilization of alpha-synuclein protein with aging and familial parkinson\u2019s disease-linked A53T mutation. J. Neurosci. 24, 7400\u20137409 (2004).","journal-title":"J. Neurosci."},{"key":"59441_CR89","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jama.296.6.661","volume":"296","author":"DM Maraganore","year":"2006","unstructured":"Maraganore, D. M. et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296, 661\u2013670 (2006).","journal-title":"JAMA"},{"key":"59441_CR90","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00439-003-1002-9","volume":"113","author":"O Chiba-Falek","year":"2003","unstructured":"Chiba-Falek, O., Touchman, J. W. & Nussbaum, R. L. Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum. Genet 113, 426\u2013431 (2003).","journal-title":"Hum. Genet"},{"key":"59441_CR91","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1093\/hmg\/ddp265","volume":"18","author":"KD Cronin","year":"2009","unstructured":"Cronin, K. D. et al. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum. Mol. Genet 18, 3274\u20133285 (2009).","journal-title":"Hum. Mol. Genet"},{"key":"59441_CR92","doi-asserted-by":"publisher","first-page":"e7480","DOI":"10.1371\/journal.pone.0007480","volume":"4","author":"C Linnertz","year":"2009","unstructured":"Linnertz, C. et al. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS One 4, e7480 (2009).","journal-title":"PLoS One"},{"key":"59441_CR93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamaneurol.2022.4193","volume":"80","author":"AJ Espay","year":"2023","unstructured":"Espay, A. J. & Okun, M. S. Abandoning the proteinopathy paradigm in parkinson disease. JAMA Neurol. 80, 123\u2013124 (2023).","journal-title":"JAMA Neurol."},{"key":"59441_CR94","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1079\/BJN19940126","volume":"71","author":"V Barzanti","year":"1994","unstructured":"Barzanti, V. et al. The effect of dietary lipid changes on the fatty acid composition and function of liver, heart and brain mitochondria in the rat at different ages. Br. J. Nutr. 71, 193\u2013202 (1994).","journal-title":"Br. J. Nutr."},{"key":"59441_CR95","first-page":"135","volume":"2","author":"A Denker","year":"2010","unstructured":"Denker, A. & Rizzoli, S. O. Synaptic vesicle pools: an update. Front Synaptic Neurosci. 2, 135 (2010).","journal-title":"Front Synaptic Neurosci."},{"key":"59441_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46256-1","volume":"15","author":"SF Longfield","year":"2024","unstructured":"Longfield, S. F. et al. Synapsin 2a tetramerisation selectively controls the presynaptic nanoscale organisation of reserve synaptic vesicles. Nat. Commun. 15, 2217 (2024).","journal-title":"Nat. Commun."},{"key":"59441_CR97","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1152\/japplphysiol.00580.2005","volume":"100","author":"S Logsdon","year":"2006","unstructured":"Logsdon, S., Johnstone, A. F., Viele, K. & Cooper, R. L. Regulation of synaptic vesicles pools within motor nerve terminals during short-term facilitation and neuromodulation. J. Appl Physiol. (1985) 100, 662\u2013671 (2006).","journal-title":"J. Appl Physiol. (1985)"},{"key":"59441_CR98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche, M., Pereira, S. L., Klein, C. & Grunewald, A. Mitochondria and parkinson\u2019s disease: clinical, molecular, and translational aspects. J. Parkinsons Dis. 11, 45\u201360 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"59441_CR99","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jnc.14820","volume":"150","author":"DJ Vidyadhara","year":"2019","unstructured":"Vidyadhara, D. J., Lee, J. E. & Chandra, S. S. Role of the endolysosomal system in Parkinson\u2019s disease. J. Neurochem 150, 487\u2013506 (2019).","journal-title":"J. Neurochem"},{"key":"59441_CR100","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","volume":"34","author":"KJ Vargas","year":"2014","unstructured":"Vargas, K. J. et al. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J. Neurosci. 34, 9364\u20139376 (2014).","journal-title":"J. Neurosci."},{"key":"59441_CR101","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/j.1471-4159.2005.03506.x","volume":"95","author":"M Morciano","year":"2005","unstructured":"Morciano, M. et al. Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis. J. Neurochem 95, 1732\u20131745 (2005).","journal-title":"J. Neurochem"},{"key":"59441_CR102","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1073\/pnas.0308186101","volume":"101","author":"F Blondeau","year":"2004","unstructured":"Blondeau, F. et al. Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proc. Natl Acad. Sci. USA 101, 3833\u20133838 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR103","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1002\/pmic.200300817","volume":"4","author":"HD Coughenour","year":"2004","unstructured":"Coughenour, H. D., Spaulding, R. S. & Thompson, C. M. The synaptic vesicle proteome: a comparative study in membrane protein identification. Proteomics 4, 3141\u20133155 (2004).","journal-title":"Proteomics"},{"key":"59441_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110675","volume":"39","author":"KE Carnazza","year":"2022","unstructured":"Carnazza, K. E. et al. Synaptic vesicle binding of alpha-synuclein is modulated by beta- and gamma-synucleins. Cell Rep. 39, 110675 (2022).","journal-title":"Cell Rep."},{"key":"59441_CR105","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich, A. et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239\u2013252 (2000).","journal-title":"Neuron"},{"key":"59441_CR106","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neurobiolaging.2016.06.020","volume":"46","author":"N Connor-Robson","year":"2016","unstructured":"Connor-Robson, N., Peters, O. M., Millership, S., Ninkina, N. & Buchman, V. L. Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism. Neurobiol. Aging 46, 107\u2013112 (2016).","journal-title":"Neurobiol. Aging"},{"key":"59441_CR107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10048-007-0079-z","volume":"8","author":"M Kuhn","year":"2007","unstructured":"Kuhn, M. et al. Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein. Neurogenetics 8, 71\u201381 (2007).","journal-title":"Neurogenetics"},{"key":"59441_CR108","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam, N. et al. Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis. 9, 4 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"59441_CR109","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas, L. A. et al. Serine-129 phosphorylatoin of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron 111, 4006\u20134023 (2023).","journal-title":"Neuron"},{"key":"59441_CR110","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0006-3495(01)75695-0","volume":"81","author":"N Fuller","year":"2001","unstructured":"Fuller, N. & Rand, R. P. The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes. Biophys. J. 81, 243\u2013254 (2001).","journal-title":"Biophys. J."},{"key":"59441_CR111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2016.02.033","volume":"90","author":"E Lauwers","year":"2016","unstructured":"Lauwers, E., Goodchild, R. & Verstreken, P. Membrane lipids in presynaptic function and disease. Neuron 90, 11\u201325 (2016).","journal-title":"Neuron"},{"key":"59441_CR112","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.bbapap.2019.05.001","volume":"1867","author":"T Das","year":"2019","unstructured":"Das, T. & Eliezer, D. Membrane interactions of intrinsically disordered proteins: The example of alpha-synuclein. Biochim Biophys. Acta Proteins Proteom. 1867, 879\u2013889 (2019).","journal-title":"Biochim Biophys. Acta Proteins Proteom."},{"key":"59441_CR113","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41594-023-01004-9","volume":"30","author":"T Yu","year":"2023","unstructured":"Yu, T., Flores-Solis, D., Eastep, G. N., Becker, S. & Zweckstetter, M. Phosphatidylserine-dependent structure of synaptogyrin remodels the synaptic vesicle membrane. Nat. Struct. Mol. Biol. 30, 926\u2013934 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59441_CR114","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1002\/1873-3468.13193","volume":"592","author":"Y Park","year":"2018","unstructured":"Park, Y. & Ryu, J. K. Models of synaptotagmin-1 to trigger Ca(2+) -dependent vesicle fusion. FEBS Lett. 592, 3480\u20133492 (2018).","journal-title":"FEBS Lett."},{"key":"59441_CR115","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.bbamem.2014.01.008","volume":"1838","author":"S Corbalan-Garcia","year":"2014","unstructured":"Corbalan-Garcia, S. & Gomez-Fernandez, J. C. Signaling through C2 domains: more than one lipid target. Biochim Biophys. Acta 1838, 1536\u20131547 (2014).","journal-title":"Biochim Biophys. Acta"},{"key":"59441_CR116","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1073\/pnas.1813194116","volume":"116","author":"NA Lakomek","year":"2019","unstructured":"Lakomek, N. A., Yavuz, H., Jahn, R. & Perez-Lara, A. Structural dynamics and transient lipid binding of synaptobrevin-2 tune SNARE assembly and membrane fusion. Proc. Natl Acad. Sci. USA 116, 8699\u20138708 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR117","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1021\/bi401638u","volume":"53","author":"B Liang","year":"2014","unstructured":"Liang, B., Dawidowski, D., Ellena, J. F., Tamm, L. K. & Cafiso, D. S. The SNARE motif of synaptobrevin exhibits an aqueous-interfacial partitioning that is modulated by membrane curvature. Biochemistry 53, 1485\u20131494 (2014).","journal-title":"Biochemistry"},{"key":"59441_CR118","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ana.21415","volume":"65","author":"C Paisan-Ruiz","year":"2009","unstructured":"Paisan-Ruiz, C. et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann. Neurol. 65, 19\u201323 (2009).","journal-title":"Ann. Neurol."},{"key":"59441_CR119","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","volume":"75","author":"H Yoshino","year":"2010","unstructured":"Yoshino, H. et al. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology 75, 1356\u20131361 (2010).","journal-title":"Neurology"},{"key":"59441_CR120","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/humu.22372","volume":"34","author":"CE Krebs","year":"2013","unstructured":"Krebs, C. E. et al. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive parkinsonism with generalized seizures. Hum. Mutat. 34, 1200\u20131207 (2013).","journal-title":"Hum. Mutat."},{"key":"59441_CR121","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/humu.22373","volume":"34","author":"M Quadri","year":"2013","unstructured":"Quadri, M. et al. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum. Mutat. 34, 1208\u20131215 (2013).","journal-title":"Hum. Mutat."},{"key":"59441_CR122","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells8010027","volume":"8","author":"H Xicoy","year":"2019","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. M. The role of lipids in parkinson\u2019s disease. Cells 8, 27 (2019).","journal-title":"Cells"},{"key":"59441_CR123","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","volume":"10","author":"M van Spronsen","year":"2010","unstructured":"van Spronsen, M. & Hoogenraad, C. C. Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep. 10, 207\u2013214 (2010).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"59441_CR124","first-page":"262","volume":"19","author":"RG Zhai","year":"2004","unstructured":"Zhai, R. G. & Bellen, H. J. The architecture of the active zone in the presynaptic nerve terminal. Physiol. (Bethesda) 19, 262\u2013270 (2004).","journal-title":"Physiol. (Bethesda)"},{"key":"59441_CR125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn1583","volume":"6","author":"SO Rizzoli","year":"2005","unstructured":"Rizzoli, S. O. & Betz, W. J. Synaptic vesicle pools. Nat. Rev. Neurosci. 6, 57\u201369 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"59441_CR126","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-020-03134-2","volume":"591","author":"S Holler","year":"2021","unstructured":"Holler, S., Kostinger, G., Martin, K. A. C., Schuhknecht, G. F. P. & Stratford, K. J. Structure and function of a neocortical synapse. Nature 591, 111\u2013116 (2021).","journal-title":"Nature"},{"key":"59441_CR127","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1042\/BCJ20170200","volume":"474","author":"X Lou","year":"2017","unstructured":"Lou, X., Kim, J., Hawk, B. J. & Shin, Y. K. alpha-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking. Biochem J. 474, 2039\u20132049 (2017).","journal-title":"Biochem J."},{"key":"59441_CR128","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1523\/JNEUROSCI.2898-12.2013","volume":"33","author":"D Boassa","year":"2013","unstructured":"Boassa, D. et al. Mapping the subcellular distribution of alpha-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson\u2019s disease pathogenesis. J. Neurosci. 33, 2605\u20132615 (2013).","journal-title":"J. Neurosci."},{"key":"59441_CR129","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1091\/mbc.e14-02-0708","volume":"25","author":"DJ Busch","year":"2014","unstructured":"Busch, D. J. et al. Acute increase of alpha-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation. Mol. Biol. Cell 25, 3926\u20133941 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"59441_CR130","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","volume":"18","author":"KJ Vargas","year":"2017","unstructured":"Vargas, K. J. et al. Synucleins have multiple effects on presynaptic architecture. Cell Rep. 18, 161\u2013173 (2017).","journal-title":"Cell Rep."},{"key":"59441_CR131","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott, D. & Roy, S. alpha-synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J. Neurosci. 32, 10129\u201310135 (2012).","journal-title":"J. Neurosci."},{"key":"59441_CR132","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani, V. M. et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66\u201379 (2010).","journal-title":"Neuron"},{"key":"59441_CR133","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"59441_CR134","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"59441_CR135","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E23-07-0269","volume":"35","author":"JN Wallace","year":"2024","unstructured":"Wallace, J. N. et al. Excess phosphoserine-129 alpha-synuclein induces synaptic vesicle trafficking and declustering defects at a vertebrate synapse. Mol. Biol. Cell 35, ar10 (2024).","journal-title":"Mol. Biol. Cell"},{"key":"59441_CR136","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1039\/C4MT00339J","volume":"7","author":"E Carboni","year":"2015","unstructured":"Carboni, E. & Lingor, P. Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson\u2019s disease. Metallomics 7, 395\u2013404 (2015).","journal-title":"Metallomics"},{"key":"59441_CR137","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jnc.14721","volume":"150","author":"N Gonzalez","year":"2019","unstructured":"Gonzalez, N. et al. Effects of alpha-synuclein post-translational modifications on metal binding. J. Neurochem 150, 507\u2013521 (2019).","journal-title":"J. Neurochem"},{"key":"59441_CR138","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1073\/pnas.1610099113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Caspase-1 causes truncation and aggregation of the parkinson\u2019s disease-associated protein alpha-synuclein. Proc. Natl Acad. Sci. USA 113, 9587\u20139592 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR139","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1074\/jbc.RA119.008930","volume":"294","author":"RP McGlinchey","year":"2019","unstructured":"McGlinchey, R. P. et al. C-terminal alpha-synuclein truncations are linked to cysteine cathepsin activity in parkinson\u2019s disease. J. Biol. Chem. 294, 9973\u20139984 (2019).","journal-title":"J. Biol. Chem."},{"key":"59441_CR140","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1021\/bi047846q","volume":"44","author":"AJ Mishizen-Eberz","year":"2005","unstructured":"Mishizen-Eberz, A. J. et al. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry 44, 7818\u20137829 (2005).","journal-title":"Biochemistry"},{"key":"59441_CR141","doi-asserted-by":"publisher","unstructured":"Bluhm, A., Schrempel, S., von Horsten, S., Schulze, A. & Rossner, S. Proteolytic alpha-synuclein cleavage in health and disease. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22115450 (2021).","DOI":"10.3390\/ijms22115450"},{"key":"59441_CR142","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41531-023-00604-y","volume":"9","author":"MF Altay","year":"2023","unstructured":"Altay, M. F. et al. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. NPJ Parkinsons Dis. 9, 161 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"59441_CR143","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jsb.2018.04.003","volume":"206","author":"S Hwang","year":"2019","unstructured":"Hwang, S. et al. Comparison of the 3D structures of mouse and human alpha-synuclein fibrils by solid-state NMR and STEM. J. Struct. Biol. 206, 43\u201348 (2019).","journal-title":"J. Struct. Biol."},{"key":"59441_CR144","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq3539","volume":"10","author":"A Sokratian","year":"2024","unstructured":"Sokratian, A. et al. Mouse alpha-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases. Sci. Adv. 10, eadq3539 (2024).","journal-title":"Sci. Adv."},{"key":"59441_CR145","doi-asserted-by":"publisher","first-page":"13465","DOI":"10.1021\/ja203979j","volume":"133","author":"L Kang","year":"2011","unstructured":"Kang, L., Wu, K. P., Vendruscolo, M. & Baum, J. The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse alpha-synuclein. J. Am. Chem. Soc. 133, 13465\u201313470 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"59441_CR146","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jmb.2012.04.009","volume":"420","author":"G Lv","year":"2012","unstructured":"Lv, G. et al. Structural comparison of mouse and human alpha-synuclein amyloid fibrils by solid-state NMR. J. Mol. Biol. 420, 99\u2013111 (2012).","journal-title":"J. Mol. Biol."},{"key":"59441_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38070-4","volume":"13","author":"T Ohgita","year":"2023","unstructured":"Ohgita, T. et al. Intramolecular interaction kinetically regulates fibril formation by human and mouse alpha-synuclein. Sci. Rep. 13, 10885 (2023).","journal-title":"Sci. Rep."},{"key":"59441_CR148","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-020-00380-w","volume":"15","author":"N Landeck","year":"2020","unstructured":"Landeck, N. et al. Two C-terminal sequence variations determine differential neurotoxicity between human and mouse alpha-synuclein. Mol. Neurodegener. 15, 49 (2020).","journal-title":"Mol. Neurodegener."},{"key":"59441_CR149","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","volume":"30","author":"KE Paleologou","year":"2010","unstructured":"Paleologou, K. E. et al. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. J. Neurosci. 30, 3184\u20133198 (2010).","journal-title":"J. Neurosci."},{"key":"59441_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46898-1","volume":"15","author":"J Hu","year":"2024","unstructured":"Hu, J. et al. Phosphorylation and O-GlcNAcylation at the same alpha-synuclein site generate distinct fibril structures. Nat. Commun. 15, 2677 (2024).","journal-title":"Nat. Commun."},{"key":"59441_CR151","doi-asserted-by":"publisher","unstructured":"Stavsky, A. et al. Synapsin E-domain is essential for alpha-synuclein function. BioRxiv, https:\/\/doi.org\/10.7554\/eLife.89687 (2023).","DOI":"10.7554\/eLife.89687"},{"key":"59441_CR152","doi-asserted-by":"publisher","first-page":"102239","DOI":"10.1016\/j.jbc.2022.102239","volume":"298","author":"G Lv","year":"2022","unstructured":"Lv, G., Ko, M. S., Das, T. & Eliezer, D. Molecular and functional interactions of alpha-synuclein with Rab3a. J. Biol. Chem. 298, 102239 (2022).","journal-title":"J. Biol. Chem."},{"key":"59441_CR153","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.pneurobio.2010.04.006","volume":"91","author":"F Cesca","year":"2010","unstructured":"Cesca, F., Baldelli, P., Valtorta, F. & Benfenati, F. The synapsins: key actors of synapse function and plasticity. Prog. Neurobiol. 91, 313\u2013348 (2010).","journal-title":"Prog. Neurobiol."},{"key":"59441_CR154","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.92.20.9235","volume":"92","author":"L Li","year":"1995","unstructured":"Li, L. et al. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. Proc. Natl Acad. Sci. USA 92, 9235\u20139239 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR155","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1083\/jcb.131.6.1789","volume":"131","author":"Y Takei","year":"1995","unstructured":"Takei, Y. et al. Synapsin I deficiency results in the structural change in the presynaptic terminals in the murine nervous system. J. Cell Biol. 131, 1789\u20131800 (1995).","journal-title":"J. Cell Biol."},{"key":"59441_CR156","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/jphysiol.2004.073494","volume":"561","author":"D Samigullin","year":"2004","unstructured":"Samigullin, D., Bill, C. A., Coleman, W. L. & Bykhovskaia, M. Regulation of transmitter release by synapsin II in mouse motor terminals. J. Physiol. 561, 149\u2013158 (2004).","journal-title":"J. Physiol."},{"key":"59441_CR157","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/375493a0","volume":"375","author":"VA Pieribone","year":"1995","unstructured":"Pieribone, V. A. et al. Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493\u2013497 (1995).","journal-title":"Nature"},{"key":"59441_CR158","doi-asserted-by":"publisher","first-page":"11368","DOI":"10.1523\/JNEUROSCI.3795-04.2004","volume":"24","author":"D Gitler","year":"2004","unstructured":"Gitler, D. et al. Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J. Neurosci. 24, 11368\u201311380 (2004).","journal-title":"J. Neurosci."},{"key":"59441_CR159","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1242\/jcs.157867","volume":"128","author":"M Zaltieri","year":"2015","unstructured":"Zaltieri, M. et al. alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. J. Cell Sci. 128, 2231\u20132243 (2015).","journal-title":"J. Cell Sci."},{"key":"59441_CR160","doi-asserted-by":"publisher","first-page":"19573","DOI":"10.1073\/pnas.1005005107","volume":"107","author":"B Greten-Harrison","year":"2010","unstructured":"Greten-Harrison, B. et al. alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl Acad. Sci. USA 107, 19573\u201319578 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR161","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1523\/JNEUROSCI.5058-11.2012","volume":"32","author":"A Orenbuch","year":"2012","unstructured":"Orenbuch, A. et al. Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals. J. Neurosci. 32, 3969\u20133980 (2012).","journal-title":"J. Neurosci."},{"key":"59441_CR162","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1073\/pnas.1903054116","volume":"116","author":"M Atias","year":"2019","unstructured":"Atias, M. et al. Synapsins regulate alpha-synuclein functions. Proc. Natl Acad. Sci. USA 116, 11116\u201311118 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.166961","volume":"433","author":"C Hoffmann","year":"2021","unstructured":"Hoffmann, C. et al. Synapsin condensates recruit alpha-synuclein. J. Mol. Biol. 433, 166961 (2021).","journal-title":"J. Mol. Biol."},{"key":"59441_CR164","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","volume":"24","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. Biol. 24, 2319\u20132326 (2014).","journal-title":"Curr. Biol."},{"key":"59441_CR165","doi-asserted-by":"publisher","first-page":"12214","DOI":"10.1523\/JNEUROSCI.1554-12.2012","volume":"32","author":"EF Fornasiero","year":"2012","unstructured":"Fornasiero, E. F. et al. Synapsins contribute to the dynamic spatial organization of synaptic vesicles in an activity-dependent manner. J. Neurosci. 32, 12214\u201312227 (2012).","journal-title":"J. Neurosci."},{"key":"59441_CR166","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1016\/j.celrep.2020.01.092","volume":"30","author":"A Pechstein","year":"2020","unstructured":"Pechstein, A. et al. Vesicle clustering in a living synapse depends on a synapsin region that mediates phase separation. Cell Rep. 30, 2594\u20132602.e2593 (2020).","journal-title":"Cell Rep."},{"key":"59441_CR167","doi-asserted-by":"publisher","first-page":"891508","DOI":"10.3389\/fmolb.2022.891508","volume":"9","author":"L Brodin","year":"2022","unstructured":"Brodin, L., Milovanovic, D., Rizzoli, S. O. & Shupliakov, O. alpha-synuclein in the synaptic vesicle liquid phase: active player or passive bystander? Front Mol. Biosci. 9, 891508 (2022).","journal-title":"Front Mol. Biosci."},{"key":"59441_CR168","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.aat5671","volume":"361","author":"D Milovanovic","year":"2018","unstructured":"Milovanovic, D., Wu, Y., Bian, X. & De Camilli, P. A liquid phase of synapsin and lipid vesicles. Science 361, 604\u2013607 (2018).","journal-title":"Science"},{"key":"59441_CR169","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1021\/bi052359b","volume":"45","author":"JK Paterson","year":"2006","unstructured":"Paterson, J. K. et al. Lipid specific activation of the murine P4-ATPase Atp8a1 (ATPase II). Biochemistry 45, 5367\u20135376 (2006).","journal-title":"Biochemistry"},{"key":"59441_CR170","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1126\/science.aay3353","volume":"365","author":"M Hiraizumi","year":"2019","unstructured":"Hiraizumi, M., Yamashita, K., Nishizawa, T. & Nureki, O. Cryo-EM structures capture the transport cycle of the P4-ATPase flippase. Science 365, 1149\u20131155 (2019).","journal-title":"Science"},{"key":"59441_CR171","doi-asserted-by":"publisher","first-page":"e97705","DOI":"10.15252\/embj.201797705","volume":"37","author":"N Takada","year":"2018","unstructured":"Takada, N. et al. Phospholipid-flipping activity of P4-ATPase drives membrane curvature. EMBO J. 37, e97705 (2018).","journal-title":"EMBO J."},{"key":"59441_CR172","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41593-023-01434-0","volume":"26","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Adaptor protein AP-3 produces synaptic vesicles that release at high frequency by recruiting phospholipid flippase ATP8A1. Nat. Neurosci. 26, 1685\u20131700 (2023).","journal-title":"Nat. Neurosci."},{"key":"59441_CR173","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1073\/pnas.0804825105","volume":"105","author":"E Yu","year":"2008","unstructured":"Yu, E. et al. Role of Rab27 in synaptic transmission at the squid giant synapse. Proc. Natl Acad. Sci. USA 105, 16003\u201316008 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR174","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14428","volume":"8","author":"ER Arias-Hervert","year":"2020","unstructured":"Arias-Hervert, E. R. et al. Actions of Rab27B-GTPase on mammalian central excitatory synaptic transmission. Physiol. Rep. 8, e14428 (2020).","journal-title":"Physiol. Rep."},{"key":"59441_CR175","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1091\/mbc.e05-12-1170","volume":"17","author":"TR Mahoney","year":"2006","unstructured":"Mahoney, T. R. et al. Regulation of synaptic transmission by RAB-3 and RAB-27 in caenorhabditis elegans. Mol. Biol. Cell 17, 2617\u20132625 (2006).","journal-title":"Mol. Biol. Cell"},{"key":"59441_CR176","doi-asserted-by":"publisher","first-page":"13441","DOI":"10.1523\/JNEUROSCI.0907-10.2010","volume":"30","author":"NJ Pavlos","year":"2010","unstructured":"Pavlos, N. J. et al. Quantitative analysis of synaptic vesicle Rabs uncovers distinct yet overlapping roles for Rab3a and Rab27b in Ca2+-triggered exocytosis. J. Neurosci. 30, 13441\u201313453 (2010).","journal-title":"J. Neurosci."},{"key":"59441_CR177","doi-asserted-by":"publisher","first-page":"e1002267","DOI":"10.1371\/journal.pbio.1002267","volume":"13","author":"T Bacaj","year":"2015","unstructured":"Bacaj, T. et al. Synaptotagmin-1 and -7 Are redundantly essential for maintaining the capacity of the readily-releasable pool of synaptic vesicles. PLoS Biol. 13, e1002267 (2015).","journal-title":"PLoS Biol."},{"key":"59441_CR178","doi-asserted-by":"publisher","first-page":"e5230","DOI":"10.1371\/journal.pone.0005230","volume":"4","author":"CW Morgans","year":"2009","unstructured":"Morgans, C. W. et al. Loss of the synaptic vesicle protein SV2B results in reduced neurotransmission and altered synaptic vesicle protein expression in the retina. PLoS One 4, e5230 (2009).","journal-title":"PLoS One"},{"key":"59441_CR179","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12035-009-8052-5","volume":"39","author":"DR Stevens","year":"2009","unstructured":"Stevens, D. R. & Rettig, J. The Ca(2+)-dependent activator protein for secretion CAPS: do I dock or do I prime? Mol. Neurobiol. 39, 62\u201372 (2009).","journal-title":"Mol. Neurobiol."},{"key":"59441_CR180","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fendo.2013.00187","volume":"4","author":"DJ James","year":"2013","unstructured":"James, D. J. & Martin, T. F. CAPS and Munc13: CATCHRs that SNARE Vesicles. Front Endocrinol. (Lausanne) 4, 187 (2013).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"59441_CR181","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.cell.2007.11.002","volume":"131","author":"WJ Jockusch","year":"2007","unstructured":"Jockusch, W. J. et al. CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. Cell 131, 796\u2013808 (2007).","journal-title":"Cell"},{"key":"59441_CR182","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/mp.2012.81","volume":"18","author":"JI Velez","year":"2013","unstructured":"Velez, J. I. et al. Pooling\/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala alzheimer\u2019s disease. Mol. Psychiatry 18, 568\u2013575 (2013).","journal-title":"Mol. Psychiatry"},{"key":"59441_CR183","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1002\/mds.29211","volume":"37","author":"O Lorenzo-Betancor","year":"2022","unstructured":"Lorenzo-Betancor, O. et al. Homozygous CADPS2 mutations cause neurodegenerative disease with lewy body-like pathology in parrots. Mov. Disord. 37, 2345\u20132354 (2022).","journal-title":"Mov. Disord."},{"key":"59441_CR184","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.bbrc.2017.06.134","volume":"490","author":"J Obergasteiger","year":"2017","unstructured":"Obergasteiger, J. et al. CADPS2 gene expression is oppositely regulated by LRRK2 and alpha-synuclein. Biochem Biophys. Res Commun. 490, 876\u2013881 (2017).","journal-title":"Biochem Biophys. Res Commun."},{"key":"59441_CR185","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.287.5454.864","volume":"287","author":"M Verhage","year":"2000","unstructured":"Verhage, M. et al. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287, 864\u2013869 (2000).","journal-title":"Science"},{"key":"59441_CR186","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1073\/pnas.91.4.1445","volume":"91","author":"J Pevsner","year":"1994","unstructured":"Pevsner, J., Hsu, S. C. & Scheller, R. H. n-Sec1: a neural-specific syntaxin-binding protein. Proc. Natl Acad. Sci. USA 91, 1445\u20131449 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR187","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1073\/pnas.91.6.2003","volume":"91","author":"EP Garcia","year":"1994","unstructured":"Garcia, E. P., Gatti, E., Butler, M., Burton, J. & De Camilli, P. A rat brain Sec1 homologue related to Rop and UNC18 interacts with syntaxin. Proc. Natl Acad. Sci. USA 91, 2003\u20132007 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR188","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev-biophys-111821-104732","volume":"51","author":"J Rizo","year":"2022","unstructured":"Rizo, J. Molecular mechanisms underlying neurotransmitter release. Annu Rev. Biophys. 51, 377\u2013408 (2022).","journal-title":"Annu Rev. Biophys."},{"key":"59441_CR189","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jnc.15120","volume":"157","author":"D Abramov","year":"2021","unstructured":"Abramov, D., Guiberson, N. G. L. & Burre, J. STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies. J. Neurochem 157, 165\u2013178 (2021).","journal-title":"J. Neurochem"},{"key":"59441_CR190","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1471-4159.2005.03128.x","volume":"93","author":"RF Toonen","year":"2005","unstructured":"Toonen, R. F., de Vries, K. J., Zalm, R., Sudhof, T. C. & Verhage, M. Munc18-1 stabilizes syntaxin 1, but is not essential for syntaxin 1 targeting and SNARE complex formation. J. Neurochem 93, 1393\u20131400 (2005).","journal-title":"J. Neurochem"},{"key":"59441_CR191","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1242\/jeb.172.1.171","volume":"172","author":"Y Moriyama","year":"1992","unstructured":"Moriyama, Y., Maeda, M. & Futai, M. The role of V-ATPase in neuronal and endocrine systems. J. Exp. Biol. 172, 171\u2013178 (1992).","journal-title":"J. Exp. Biol."},{"key":"59441_CR192","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrm2272","volume":"8","author":"M Forgac","year":"2007","unstructured":"Forgac, M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8, 917\u2013929 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59441_CR193","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1242\/jcs.00791","volume":"116","author":"N Morel","year":"2003","unstructured":"Morel, N., Dedieu, J. C. & Philippe, J. M. Specific sorting of the a1 isoform of the V-H+ATPase a subunit to nerve terminals where it associates with both synaptic vesicles and the presynaptic plasma membrane. J. Cell Sci. 116, 4751\u20134762 (2003).","journal-title":"J. Cell Sci."},{"key":"59441_CR194","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.celrep.2017.07.040","volume":"20","author":"A Bodzeta","year":"2017","unstructured":"Bodzeta, A., Kahms, M. & Klingauf, J. The Presynaptic v-ATpase reversibly disassembles and thereby modulates exocytosis but is not part of the fusion machinery. Cell Rep. 20, 1348\u20131359 (2017).","journal-title":"Cell Rep."},{"key":"59441_CR195","doi-asserted-by":"publisher","first-page":"e32569","DOI":"10.7554\/eLife.32569","volume":"7","author":"Z Farsi","year":"2018","unstructured":"Farsi, Z. et al. Clathrin coat controls synaptic vesicle acidification by blocking vacuolar ATPase activity. Elife 7, e32569 (2018).","journal-title":"Elife"},{"key":"59441_CR196","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1469-7793.2000.t01-1-00195.x","volume":"525","author":"Q Zhou","year":"2000","unstructured":"Zhou, Q., Petersen, C. C. & Nicoll, R. A. Effects of reduced vesicular filling on synaptic transmission in rat hippocampal neurones. J. Physiol. 525, 195\u2013206 (2000).","journal-title":"J. Physiol."},{"key":"59441_CR197","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/nn.4161","volume":"18","author":"BR Rost","year":"2015","unstructured":"Rost, B. R. et al. Optogenetic acidification of synaptic vesicles and lysosomes. Nat. Neurosci. 18, 1845\u20131852 (2015).","journal-title":"Nat. Neurosci."},{"key":"59441_CR198","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.1252884","volume":"344","author":"BG Wilhelm","year":"2014","unstructured":"Wilhelm, B. G. et al. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344, 1023\u20131028 (2014).","journal-title":"Science"},{"key":"59441_CR199","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2005.03.012","volume":"121","author":"PR Hiesinger","year":"2005","unstructured":"Hiesinger, P. R. et al. The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 121, 607\u2013620 (2005).","journal-title":"Cell"},{"key":"59441_CR200","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.1074\/jbc.RA118.006192","volume":"294","author":"M Abe","year":"2019","unstructured":"Abe, M. et al. Functional complementation reveals that 9 of the 13 human V-ATPase subunits can functionally substitute for their yeast orthologs. J. Biol. Chem. 294, 8273\u20138285 (2019).","journal-title":"J. Biol. Chem."},{"key":"59441_CR201","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.1523\/JNEUROSCI.6305-11.2012","volume":"32","author":"G Cheung","year":"2012","unstructured":"Cheung, G. & Cousin, M. A. Adaptor protein complexes 1 and 3 are essential for generation of synaptic vesicles from activity-dependent bulk endosomes. J. Neurosci. 32, 6014\u20136023 (2012).","journal-title":"J. Neurosci."},{"key":"59441_CR202","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1146\/annurev-biochem-062917-012644","volume":"87","author":"M Mettlen","year":"2018","unstructured":"Mettlen, M., Chen, P. H., Srinivasan, S., Danuser, G. & Schmid, S. L. Regulation of clathrin-mediated endocytosis. Annu Rev. Biochem 87, 871\u2013896 (2018).","journal-title":"Annu Rev. Biochem"},{"key":"59441_CR203","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/emboj.2010.15","volume":"29","author":"N Glyvuk","year":"2010","unstructured":"Glyvuk, N. et al. AP-1\/sigma1B-adaptin mediates endosomal synaptic vesicle recycling, learning and memory. EMBO J. 29, 1318\u20131330 (2010).","journal-title":"EMBO J."},{"key":"59441_CR204","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.neuron.2018.06.005","volume":"98","author":"S Watanabe","year":"2018","unstructured":"Watanabe, S. et al. Synaptojanin and endophilin mediate neck formation during ultrafast endocytosis. Neuron 98, 1184\u20131197.e1186 (2018).","journal-title":"Neuron"},{"key":"59441_CR205","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10048-014-0406-0","volume":"15","author":"S Olgiati","year":"2014","unstructured":"Olgiati, S. et al. PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family. Neurogenetics 15, 183\u2013188 (2014).","journal-title":"Neurogenetics"},{"key":"59441_CR206","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.celrep.2018.05.011","volume":"23","author":"AM Miranda","year":"2018","unstructured":"Miranda, A. M. et al. Excess Synaptojanin 1 Contributes to place cell dysfunction and memory deficits in the aging hippocampus in three types of alzheimer\u2019s disease. Cell Rep. 23, 2967\u20132975 (2018).","journal-title":"Cell Rep."},{"key":"59441_CR207","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1073\/pnas.1510011112","volume":"112","author":"L Zhu","year":"2015","unstructured":"Zhu, L. et al. Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in alzheimer\u2019s disease pathogenesis. Proc. Natl Acad. Sci. USA 112, 11965\u201311970 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR208","doi-asserted-by":"publisher","first-page":"9415","DOI":"10.1073\/pnas.0803756105","volume":"105","author":"SV Voronov","year":"2008","unstructured":"Voronov, S. V. et al. Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down\u2019s syndrome. Proc. Natl Acad. Sci. USA 105, 9415\u20139420 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR209","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0092-8674(00)81649-9","volume":"99","author":"O Cremona","year":"1999","unstructured":"Cremona, O. et al. Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99, 179\u2013188 (1999).","journal-title":"Cell"},{"key":"59441_CR210","doi-asserted-by":"publisher","first-page":"756.e711","DOI":"10.1016\/j.neurobiolaging.2010.11.022","volume":"32","author":"JC Lambert","year":"2011","unstructured":"Lambert, J. C. et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol. Aging 32, 756.e711\u2013755 (2011).","journal-title":"Neurobiol. Aging"},{"key":"59441_CR211","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/cells11243994","volume":"11","author":"K Ando","year":"2022","unstructured":"Ando, K. et al. PICALM and alzheimer\u2019s disease: An update and perspectives. Cells 11, 3994 (2022).","journal-title":"Cells"},{"key":"59441_CR212","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00109-014-1138-1","volume":"92","author":"I Prokic","year":"2014","unstructured":"Prokic, I., Cowling, B. S. & Laporte, J. Amphiphysin 2 (BIN1) in physiology and diseases. J. Mol. Med (Berl.) 92, 453\u2013463 (2014).","journal-title":"J. Mol. Med (Berl.)"},{"key":"59441_CR213","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1016\/j.celrep.2020.02.026","volume":"30","author":"P De Rossi","year":"2020","unstructured":"De Rossi, P. et al. Neuronal BIN1 regulates presynaptic neurotransmitter release and memory consolidation. Cell Rep. 30, 3520\u20133535.e3527 (2020).","journal-title":"Cell Rep."},{"key":"59441_CR214","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1600-0854.2005.00355.x","volume":"6","author":"A Meyerholz","year":"2005","unstructured":"Meyerholz, A. et al. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 6, 1225\u20131234 (2005).","journal-title":"Traffic"},{"key":"59441_CR215","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12017-012-8194-x","volume":"15","author":"RS Petralia","year":"2013","unstructured":"Petralia, R. S. et al. Reduction of AP180 and CALM produces defects in synaptic vesicle size and density. Neuromolecular Med 15, 49\u201360 (2013).","journal-title":"Neuromolecular Med"},{"key":"59441_CR216","doi-asserted-by":"publisher","first-page":"e91242","DOI":"10.1371\/journal.pone.0091242","volume":"9","author":"I Parikh","year":"2014","unstructured":"Parikh, I., Fardo, D. W. & Estus, S. Genetics of PICALM expression and Alzheimer\u2019s disease. PLoS One 9, e91242 (2014).","journal-title":"PLoS One"},{"key":"59441_CR217","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/alzrt71","volume":"3","author":"EH Kok","year":"2011","unstructured":"Kok, E. H. et al. CLU, CR1 and PICALM genes associate with Alzheimer\u2019s-related senile plaques. Alzheimers Res Ther. 3, 12 (2011).","journal-title":"Alzheimers Res Ther."},{"key":"59441_CR218","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-013-1111-z","volume":"125","author":"K Ando","year":"2013","unstructured":"Ando, K. et al. Clathrin adaptor CALM\/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer\u2019s brains. Acta Neuropathol. 125, 861\u2013878 (2013).","journal-title":"Acta Neuropathol."},{"key":"59441_CR219","doi-asserted-by":"publisher","first-page":"eadc9317","DOI":"10.1126\/sciadv.adc9317","volume":"8","author":"JH Yoon","year":"2022","unstructured":"Yoon, J. H. et al. Brain lipidomics: From functional landscape to clinical significance. Sci. Adv. 8, eadc9317 (2022).","journal-title":"Sci. Adv."},{"key":"59441_CR220","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tcb.2015.03.004","volume":"25","author":"B Antonny","year":"2015","unstructured":"Antonny, B., Vanni, S., Shindou, H. & Ferreira, T. From zero to six double bonds: phospholipid unsaturation and organelle function. Trends Cell Biol. 25, 427\u2013436 (2015).","journal-title":"Trends Cell Biol."},{"key":"59441_CR221","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.irn.2015.05.008","volume":"122","author":"A Naudi","year":"2015","unstructured":"Naudi, A. et al. Lipidomics of human brain aging and Alzheimer\u2019s disease pathology. Int Rev. Neurobiol. 122, 133\u2013189 (2015).","journal-title":"Int Rev. Neurobiol."},{"key":"59441_CR222","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1023\/B:NERE.0000026394.92363.ee","volume":"29","author":"ES Lee","year":"2004","unstructured":"Lee, E. S. et al. Inhibitory effects of lysophosphatidylcholine on the dopaminergic system. Neurochem Res 29, 1333\u20131342 (2004).","journal-title":"Neurochem Res"},{"key":"59441_CR223","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1002\/jcp.25815","volume":"232","author":"S Lobasso","year":"2017","unstructured":"Lobasso, S. et al. Lipid profiling of parkin-mutant human skin fibroblasts. J. Cell Physiol. 232, 3540\u20133551 (2017).","journal-title":"J. Cell Physiol."},{"key":"59441_CR224","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.12659\/MSM.904399","volume":"23","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Zhang, X., Wang, L. & Yang, C. High performance liquid chromatography-mass spectrometry (LC-MS) based quantitative lipidomics study of ganglioside-NANA-3 plasma to establish its association with parkinson\u2019s disease patients. Med Sci. Monit. 23, 5345\u20135353 (2017).","journal-title":"Med Sci. Monit."},{"key":"59441_CR225","doi-asserted-by":"publisher","first-page":"e0191815","DOI":"10.1371\/journal.pone.0191815","volume":"13","author":"PL Wood","year":"2018","unstructured":"Wood, P. L., Tippireddy, S., Feriante, J. & Woltjer, R. L. Augmented frontal cortex diacylglycerol levels in parkinson\u2019s disease and lewy body disease. PLoS One 13, e0191815 (2018).","journal-title":"PLoS One"},{"key":"59441_CR226","doi-asserted-by":"publisher","DOI":"10.1177\/1759091418781889","volume":"10","author":"TN Seyfried","year":"2018","unstructured":"Seyfried, T. N. et al. Sex-related abnormalities in substantia nigra lipids in parkinson\u2019s disease. ASN Neuro 10, 1759091418781889 (2018).","journal-title":"ASN Neuro"},{"key":"59441_CR227","doi-asserted-by":"publisher","first-page":"18865","DOI":"10.3390\/ijms160818865","volume":"16","author":"K Farmer","year":"2015","unstructured":"Farmer, K., Smith, C. A., Hayley, S. & Smith, J. Major alterations of phosphatidylcholine and lysophosphotidylcholine lipids in the substantia nigra using an early stage model of parkinson\u2019s disease. Int J. Mol. Sci. 16, 18865\u201318877 (2015).","journal-title":"Int J. Mol. Sci."},{"key":"59441_CR228","doi-asserted-by":"publisher","first-page":"e17299","DOI":"10.1371\/journal.pone.0017299","volume":"6","author":"D Cheng","year":"2011","unstructured":"Cheng, D. et al. Lipid pathway alterations in parkinson\u2019s disease primary visual cortex. PLoS One 6, e17299 (2011).","journal-title":"PLoS One"},{"key":"59441_CR229","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0306-4522(00)00501-7","volume":"102","author":"BM Ross","year":"2001","unstructured":"Ross, B. M., Mamalias, N., Moszczynska, A., Rajput, A. H. & Kish, S. J. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson\u2019s disease. Neuroscience 102, 899\u2013904 (2001).","journal-title":"Neuroscience"},{"key":"59441_CR230","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archneur.1975.00490430047006","volume":"32","author":"P Riekkinen","year":"1975","unstructured":"Riekkinen, P., Rinne, U. K., Pelliniemi, T. T. & Sonninen, V. Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients. Arch. Neurol. 32, 25\u201327 (1975).","journal-title":"Arch. Neurol."},{"key":"59441_CR231","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11357-022-00527-1","volume":"44","author":"N Mota-Martorell","year":"2022","unstructured":"Mota-Martorell, N. et al. Selective brain regional changes in lipid profile with human aging. Geroscience 44, 763\u2013783 (2022).","journal-title":"Geroscience"},{"key":"59441_CR232","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1091\/mbc.e09-08-0691","volume":"20","author":"Z Zhang","year":"2009","unstructured":"Zhang, Z., Hui, E., Chapman, E. R. & Jackson, M. B. Phosphatidylserine regulation of Ca2+-triggered exocytosis and fusion pores in PC12 cells. Mol. Biol. Cell 20, 5086\u20135095 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"59441_CR233","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","volume":"1831","author":"JE Vance","year":"2013","unstructured":"Vance, J. E. & Tasseva, G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim Biophys. Acta 1831, 543\u2013554 (2013).","journal-title":"Biochim Biophys. Acta"},{"key":"59441_CR234","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310174120","volume":"120","author":"Y Lai","year":"2023","unstructured":"Lai, Y. et al. Neutral lysophosphatidylcholine mediates alpha-synuclein-induced synaptic vesicle clustering. Proc. Natl Acad. Sci. USA 120, e2310174120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR235","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwae182","volume":"11","author":"C Zhao","year":"2024","unstructured":"Zhao, C. et al. Lysophosphatidylcholine binds alpha-synuclein and prevents its pathological aggregation. Natl Sci. Rev. 11, nwae182 (2024).","journal-title":"Natl Sci. Rev."},{"key":"59441_CR236","doi-asserted-by":"publisher","first-page":"136491","DOI":"10.1016\/j.neulet.2022.136491","volume":"772","author":"JW Nicholatos","year":"2022","unstructured":"Nicholatos, J. W., Tran, D., Liu, Y., Hirst, W. D. & Weihofen, A. Lysophosphatidylcholine acyltransferase 1 promotes pathology and toxicity in two distinct cell-based alpha-synuclein models. Neurosci. Lett. 772, 136491 (2022).","journal-title":"Neurosci. Lett."},{"key":"59441_CR237","doi-asserted-by":"publisher","unstructured":"Nakahara, Y. et al. Genome-wide association study identifies a new susceptibility locus in PLA2G4C for multiple system atrophy. medRxiv https:\/\/doi.org\/10.1101\/2023.05.02.23289328 (2023).","DOI":"10.1101\/2023.05.02.23289328"},{"key":"59441_CR238","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s40120-023-00542-0","volume":"12","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Effect of PLA2G6 and SMPD1 variants on the lipid metabolism in the cerebrospinal fluid of patients with parkinson\u2019s disease: A non-targeted lipidomics study. Neurol. Ther. 12, 2021\u20132040 (2023).","journal-title":"Neurol. Ther."},{"key":"59441_CR239","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","volume":"99","author":"ER Middleton","year":"2010","unstructured":"Middleton, E. R. & Rhoades, E. Effects of curvature and composition on alpha-synuclein binding to lipid vesicles. Biophys. J. 99, 2279\u20132288 (2010).","journal-title":"Biophys. J."},{"key":"59441_CR240","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/bip.20440","volume":"84","author":"M Bisaglia","year":"2006","unstructured":"Bisaglia, M., Schievano, E., Caporale, A., Peggion, E. & Mammi, S. The 11-mer repeats of human alpha-synuclein in vesicle interactions and lipid composition discrimination: a cooperative role. Biopolymers 84, 310\u2013316 (2006).","journal-title":"Biopolymers"},{"key":"59441_CR241","doi-asserted-by":"publisher","first-page":"E3976","DOI":"10.1073\/pnas.1411694111","volume":"111","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Phosphatidylethanolamine deficiency disrupts alpha-synuclein homeostasis in yeast and worm models of parkinson disease. Proc. Natl Acad. Sci. USA 111, E3976\u2013E3985 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR242","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma, M. & Burre, J. alpha-Synuclein in synaptic function and dysfunction. Trends Neurosci. 46, 153\u2013166 (2023).","journal-title":"Trends Neurosci."},{"key":"59441_CR243","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1039\/D3SC05661A","volume":"15","author":"AJ Dear","year":"2024","unstructured":"Dear, A. J. et al. Molecular mechanism of alpha-synuclein aggregation on lipid membranes revealed. Chem. Sci. 15, 7229\u20137242 (2024).","journal-title":"Chem. Sci."},{"key":"59441_CR244","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion, C. et al. Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation. Nat. Chem. Biol. 11, 229\u2013234 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"59441_CR245","doi-asserted-by":"publisher","first-page":"e77235","DOI":"10.1371\/journal.pone.0077235","volume":"8","author":"E Hellstrand","year":"2013","unstructured":"Hellstrand, E., Nowacka, A., Topgaard, D., Linse, S. & Sparr, E. Membrane lipid co-aggregation with alpha-synuclein fibrils. PLoS One 8, e77235 (2013).","journal-title":"PLoS One"},{"key":"59441_CR246","doi-asserted-by":"publisher","first-page":"622764","DOI":"10.3389\/fcell.2021.622764","volume":"9","author":"R Gaspar","year":"2021","unstructured":"Gaspar, R., Idini, I., Carlstrom, G., Linse, S. & Sparr, E. Transient lipid-protein structures and selective ganglioside uptake during alpha-synuclein-lipid co-aggregation. Front Cell Dev. Biol. 9, 622764 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"59441_CR247","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbamem.2011.09.008","volume":"1818","author":"I Dikiy","year":"2012","unstructured":"Dikiy, I. & Eliezer, D. Folding and misfolding of alpha-synuclein on membranes. Biochim Biophys. Acta 1818, 1013\u20131018 (2012).","journal-title":"Biochim Biophys. Acta"},{"key":"59441_CR248","doi-asserted-by":"publisher","first-page":"113891","DOI":"10.1016\/j.biopha.2022.113891","volume":"156","author":"T Karaki","year":"2022","unstructured":"Karaki, T., Haniu, H., Matsuda, Y. & Tsukahara, T. Lysophospholipids-potent candidates for brain food, protects neuronal cells against alpha-Synuclein aggregation. Biomed. Pharmacother. 156, 113891 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"59441_CR249","doi-asserted-by":"publisher","first-page":"562241","DOI":"10.3389\/fcell.2020.562241","volume":"8","author":"M Kiechle","year":"2020","unstructured":"Kiechle, M., Grozdanov, V. & Danzer, K. M. The role of lipids in the initiation of alpha-synuclein misfolding. Front Cell Dev. Biol. 8, 562241 (2020).","journal-title":"Front Cell Dev. Biol."},{"key":"59441_CR250","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/mt.2010.137","volume":"18","author":"OS Gorbatyuk","year":"2010","unstructured":"Gorbatyuk, O. S. et al. alpha-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Mol. Ther. 18, 1758\u20131768 (2010).","journal-title":"Mol. Ther."},{"key":"59441_CR251","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jmb.2007.01.021","volume":"367","author":"M Di Fulvio","year":"2007","unstructured":"Di Fulvio, M., Frondorf, K., Henkels, K. M., Lehman, N. & Gomez-Cambronero, J. The Grb2\/PLD2 interaction is essential for lipase activity, intracellular localization and signaling in response to EGF. J. Mol. Biol. 367, 814\u2013824 (2007).","journal-title":"J. Mol. Biol."},{"key":"59441_CR252","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/ncb1594","volume":"9","author":"C Zhao","year":"2007","unstructured":"Zhao, C., Du, G., Skowronek, K., Frohman, M. A. & Bar-Sagi, D. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat. Cell Biol. 9, 706\u2013712 (2007).","journal-title":"Nat. Cell Biol."},{"key":"59441_CR253","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/15216540600871142","volume":"58","author":"R Cazzolli","year":"2006","unstructured":"Cazzolli, R., Shemon, A. N., Fang, M. Q. & Hughes, W. E. Phospholipid signalling through phospholipase D and phosphatidic acid. IUBMB Life 58, 457\u2013461 (2006).","journal-title":"IUBMB Life"},{"key":"59441_CR254","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00210-007-0131-4","volume":"374","author":"PA Oude Weernink","year":"2007","unstructured":"Oude Weernink, P. A., Lopez de Jesus, M. & Schmidt, M. Phospholipase D signaling: orchestration by PIP2 and small GTPases. Naunyn Schmiedebergs Arch. Pharm. 374, 399\u2013411 (2007).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"59441_CR255","doi-asserted-by":"crossref","unstructured":"Barbuti, P. A. et al. The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria-ER membranes. BioRxiv (2024).","DOI":"10.1101\/2024.06.17.599406"},{"key":"59441_CR256","doi-asserted-by":"publisher","first-page":"20883","DOI":"10.1074\/jbc.M113.478297","volume":"288","author":"MM Ouberai","year":"2013","unstructured":"Ouberai, M. M. et al. alpha-synuclein senses lipid packing defects and induces lateral expansion of lipids leading to membrane remodeling. J. Biol. Chem. 288, 20883\u201320895 (2013).","journal-title":"J. Biol. Chem."},{"key":"59441_CR257","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jnc.13713","volume":"138","author":"K Lepeta","year":"2016","unstructured":"Lepeta, K. et al. Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students. J. Neurochem 138, 785\u2013805 (2016).","journal-title":"J. Neurochem"},{"key":"59441_CR258","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl Acad. Sci. USA 106, 20051\u201320056 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59441_CR259","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"59441_CR260","doi-asserted-by":"publisher","first-page":"e78055","DOI":"10.7554\/eLife.78055","volume":"11","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Synaptic location is a determinant of the detrimental effects of alpha-synuclein pathology to glutamatergic transmission in the basolateral amygdala. Elife 11, e78055 (2022).","journal-title":"Elife"},{"key":"59441_CR261","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.brainres.2012.04.018","volume":"1459","author":"JG Quinn","year":"2012","unstructured":"Quinn, J. G. et al. alpha-Synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson\u2019s disease, dementia with Lewy bodies, and Alzheimer\u2019s disease. Brain Res 1459, 71\u201380 (2012).","journal-title":"Brain Res"},{"key":"59441_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","volume":"106","author":"AA Farooqui","year":"2000","unstructured":"Farooqui, A. A., Horrocks, L. A. & Farooqui, T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106, 1\u201329 (2000).","journal-title":"Chem. Phys. Lipids"},{"key":"59441_CR263","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00216-020-03009-5","volume":"413","author":"Q Fu","year":"2021","unstructured":"Fu, Q. et al. Comparison of MS(2), synchronous precursor selection MS(3), and real-time search MS(3) methodologies for lung proteomes of hydrogen sulfide treated swine. Anal. Bioanal. Chem. 413, 419\u2013429 (2021).","journal-title":"Anal. Bioanal. Chem."},{"key":"59441_CR264","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res"},{"key":"59441_CR265","doi-asserted-by":"publisher","first-page":"13188","DOI":"10.3390\/ijms222413188","volume":"22","author":"R Bhawal","year":"2021","unstructured":"Bhawal, R., Fu, Q., Anderson, E. T., Gibson, G. E. & Zhang, S. Serum metabolomic and lipidomic profiling reveals novel biomarkers of efficacy for benfotiamine in alzheimer\u2019s disease. Int J. Mol. Sci. 22, 13188 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"59441_CR266","doi-asserted-by":"publisher","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","volume":"44","author":"M Sud","year":"2016","unstructured":"Sud, M. et al. Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res 44, D463\u2013D470 (2016).","journal-title":"Nucleic Acids Res"},{"key":"59441_CR267","doi-asserted-by":"crossref","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G. *Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res Methods 39, 175\u2013191 (2007).","DOI":"10.3758\/BF03193146"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59441-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59441-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59441-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:04:13Z","timestamp":1746083053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59441-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":267,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59441"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59441-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4079"}}